Projects

“Duplex Sans Duplex”

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - 65535

Project Lead

Dr. Shubha AM

Authors

Dr. Rajkiran S, Dr. Jobin Pathrose, Dr. Dyan D'Souza and Dr. Shubha AM

Project Status

completed